Yi Hong Yao

Directeur Technique/Scientifique/R&D chez CELLULAR BIOMEDICINE GROUP, INC.

59 ans

Consumer Services

Health Technology

Profil

Yi Hong Yao is currently Chief Scientific Officer at AbelZeta Pharma, Inc. since 2015.
Formerly, Dr. Yao was Director at MedImmune LLC from 2011 to 2015.
Education includes graduate studies at Boston University, a doctorate from the University of Kansas, and undergraduate studies at Fudan University.

Postes actifs de Yi Hong Yao

Sociétés	Poste	Début
CELLULAR BIOMEDICINE GROUP, INC.	Directeur Technique/Scientifique/R&D	01/08/2015

Tous les postes actifs de Yi Hong Yao

Anciens postes connus de Yi Hong Yao

Sociétés	Poste	Fin
MedImmune LLC MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Directeur/Membre du Conseil	01/07/2015

Voir l'expérience en détail de Yi Hong Yao

Formation de Yi Hong Yao

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Yi Hong Yao

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	5
MedImmune LLC MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Kansas University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fudan University Fudan University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AbelZeta Pharma, Inc. AbelZeta Pharma, Inc. BiotechnologyHealth Technology Develops cell therapies to cure cancer and inflammatory & immunological diseases	Health Technology